Aurobindo gets EDQM nod for domperidone and domperidone maleate

City-based pharma major Aurobindo Pharma Ltd has been granted the Certificate of Suitability of monographs of the European Pharmacopoeia by the European Directorate for the Quality of Medicines (EDQM) for its active pharmaceutical ingredients (API) domperidone and domperidone maleate.

Domperidone is a commonly used product in gastrointestinal disorders like vomiting. The company has started receiving approvals to penetrate the European market. The company has filed several DMFs/CoS/ formulation dossiers with various applicable authorities in Europe for its product range. With the endorsement from European Directorate for the Quality of Medicines (EDQM), the company will be able to sell the above products in whole of Europe, a company release stated here.